Resident Reporter-March 2013

The hematology/oncology residency is typically a focused experience in which the trainees work to enrich their hematology/oncology knowledge and enhance their clinical skills.

Highlights From Key Hematology and Oncology Congresses

Katie E. Long, PharmD; Lynne Lederman, PhD

Dr J. Bellmunt, University Hospital del Mar-IMIM, Barcelona, Spain, presented “Molecular Insights and Treatment Outlook for GU Malignancies.”1 Cabazitaxel, a taxane derivative targeting microtubules, has proven efficacy in castrate-resistant prostate cancer (CRPC) for which docetaxel has failed.

Results 1 - 2 of 2

To sign up for our newsletter or print publications, please enter your contact information below and click "Subscribe".

I'd like to receive:

TOP Print Edition

TOP Weekly e‑Newsletter

I have reviewed and consent to the terms of TOP's Privacy Policy, and TOP has my permission to retain my information in its database, and to forward pertinent communications to me.